Robert F. Kennedy Jr. to investigate risks of antidepressants after ‘more addictive than heroin’ claim
Robert F. Kennedy Jr. is launching a review of SSRIs, antidepressants, stimulants, and weight-loss drugs, questioning their ...
Is RFK Jr. actually banning SSRIs? Here’s what Floridians taking antidepressants need to know
President Donald Trump issued an executive order last week for a team to study the use of antidepressants in children.
Robert F. Kennedy Jr. says antidepressants are harder to quit than heroin—is he right?
Robert F. Kennedy Jr. has been sworn in as the US health and human services secretary, despite saying a few things that ...
Trump, RFK Jr. go after antidepressants, weight loss drugs. Here's what the science says
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
USA TODAY on MSN4d
Trump, RFK Jr. go after SSRIs in executive order. Here's how they work
SSRIs are a focus of a new Trump executive order that installs Robert F. Kennedy Jr.'s 'Make America Healthy Again' commission. Here's what they do.
Verywell Health on MSN5d
RFK Jr. Says Antidepressants Are More Addictive Than Heroin. Here Are the Facts
Kennedy Jr. is now the Secretary of Health and Human Services. Hours after Kennedy was sworn in, President Donald Trump ...
Medical Experts React to RFK Jr.'s Antidepressant Drug Remarks
Around 13.2 percent of U.S. adults were using antidepressants between 2017 and 2018, according to the Centers for Disease ...
Fast Company5d
Fact check: RFK Jr. suggested that SSRIs are as addictive as heroin. Here’s why that’s wrong
During Robert F. Kennedy Jr.’s Senate confirmation hearing for ... time getting off of SSRIs than they have getting off of heroin,” Kennedy responded. While many of Kennedy’s beliefs are ...
RFK Jr. to take aim at medications like Lexapro, Zoloft, Paxil
More than 1 in 10 people in the United States takes an antidepressant, and SSRIs are the most commonly prescribed type of ...
With RFK Jr. in charge, supplement makers see chance to cash in
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...